Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Baxter
McKinsey
Moodys
Harvard Business School
Medtronic
Merck

Last Updated: November 13, 2019

DrugPatentWatch Database Preview

Litigation Details for Abbott Laboratories v. Mylan Pharmaceuticals, Inc. (N.D. Ill. )

See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in Abbott Laboratories v. Mylan Pharmaceuticals, Inc.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial , and   Start Trial .

Details for Abbott Laboratories v. Mylan Pharmaceuticals, Inc. (N.D. Ill. )

Date Filed Document No. Description Snippet Link To Document
2007-02-23 111 two of these patents, Nos. 4,988,731 (“the ‘731 patent”) and 5,212,326 (“the ‘326 patent”).1 Mylan counterclaims…;s, Abbott procured a number of patents from the United States Patent and Trademark Office (“PTO”) in…Inc., (“Mylan”) for alleged infringement of two patents used in the manufacture of the pharmaceutical …that Abbott’s procurement and enforcement of the patents constitute federal antitrust violations. Abbott…’s June 13, 2006 Memorandum Opinion and Order. patents, two individual employees of Abbott made misrepresentations External link to document
2006-03-28 45 holds two patents for Sodium Hydrogen Divalproate Oligomer, Patent No. 4,988,731 and Patent No. 5,212,326…or more of its patents, the patent holder has 45 days in which to file suit for patent infringement or…an ANDA is an act of patent infringement. See 35 U.S.C. §271(e)(2). Once a patent holder has received … from patent infringement, and Abbott certainly has an interest in obtaining relief from patent infringement…the same body of patent law. See id. (addressing the same five factors in a patent infringement cases External link to document
2006-06-13 90 (“Compound Patents”), and six patents for formulation of the drug, Patent Nos. 6,419,953; 6,511,678;…for patent infringement. 21 U.S.C. § 355(j)(5)(B)(iii). If the patent holder files suit for patent infringement…the Compound Patents; the link between the Compound Patents and the Formulation Patents is the fact that…certifications for five patents, one compound patent and four method patents. The patentee Novartis sued…Pharmaceuticals, Inc., (“Mylan”) for patent infringement on two patents for the pharmaceutical compound External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Moodys
Express Scripts
AstraZeneca
Merck
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.